Non Surgical Peri-implant Mucositis Treatment in Patients With Tissue-level and Bone-level Implants

Analysis of the Treatment of Non-surgical Peri-implant Mucositis Treatment in Patients With Tissue-level (TL) and Bone-level (BL) Implants

This study is designed to compare the resolution of inflammation of naturally-occurring peri-implant mucositis (PM) at tissue-level (TL) and bone-level (BL) implants after non-surgical mechanical debridement.

Group A: Peri-implant mucositis (PM) at tissue-level (TL) implants after non-surgical mechanical debridement.

Group B: Peri-implant mucositis (PM) bone-level (BL) implants after non-surgical mechanical debridement.

Inclusion criteria:

• Male and female aged > 18 years
• TL and BL titanium implants with smooth necks supporting cemented or screw-retained single-unit crowns diagnosed with PM (Berglundh, et al.,2018)
• Implants placed in both arches
• Patients with gingivitis or treated periodontitis (i.e., absence of residual PD > 5 mm)
• Presence of at least 2 mm of keratinized mucosa at implant sites.

Exclusion criteria:

• presence of medical conditions contraindicating treatment of peri-implant mucositis,

• regular use of anti-inflammatory drugs or antibiotics within 3 months prior to study enrollment

  • Presence of systemic diseases
  • Pregnant and lactating females
  • Smokers > 10 cigarettes/day
  • Use of inflammatory drugs or antibiotics within 3 months prior to study recruitment
  • Implants with modified (i.e. micro-rough) necks
  • Interproximal open contacts between implant restoration and adjacent teeth
  • Peri-implantitis (Renvert, et al., 2018)